Evaluation of Hepatobiliary Function by Hepatobiliary Scintigraphy in Hepatoma Patients after Transcatheter Arterial Embolization

Author： Kao C.-H. Tsai S.-C. Wang J.-J. Ho Y.-J. Ho S.-T.

Publisher： Informa Healthcare

ISSN： 0036-5521

Source： Scandinavian Journal of Gastroenterology, Vol.36, Iss.5, 2001-05, pp. : 553-557

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Background: Transcatheter arterial embolization (TAE) is the treatment of choice for inoperable hepatocellular carcinoma. However, altered and impaired gallbladder function due to gallbladder infarction and bile duct necrosis following TAE have been reported. Methods: Hepatobiliary function was evaluated using quantitative Tc-99m DISIDA hepatobiliary scintigraphy in 40 hepatoma patients before and after TAE. The patients were separated into two groups: group 1 (20 patients), who received pre-cystic artery TAE, and group 2 (also 20 patients), who received post-cystic artery TAE. Results: After TAE, there were no significant changes in liver or bile duct function in the patients of either group. However, for group 1 patients, significantly decreased gallbladder function was found after TAE. Conclusions: Altered and impaired gallbladder function is common in hepatoma patients who receive pre-cystic artery TAE, and Tc-99m DISIDA cholescintigraphy may be useful for evaluating hepatobiliary function in hepatoma patients who receive TAE.